Friend us on facebook Become a fan on Facebook  
       

Contact Us Here:

first name
last name
phone
email
comments
 
 

The Myelin Project

P.O. Box 39,
Pacific Palisades,
CA  90272-0039

User Name:
Password:
Remember Login:
 
Forgot your password?
 
Or, to request a login for this site, click here.


MYELIN NEWS - November


Myelin News


November 22nd, 2011


 
The leukodystrophies are serious, progressive disorders of demyelination, manifesting themselves in infancy or early childhood and progressing rapidly, leading to loss of sight, hearing, speech, and ambulation, and early death. A comprehensive guide to the genetics and pathogenesis of these disorders, as well as their clinical features, diagnosis and therapy, is needed, particularly as their early identification can allow more effective treatment.  Read more...
 

November 21st, 2011


"MSRCNY Recieves Approval For Groundbreaking Stem Cell Research Trial in Multiple Sclerosis"

 

November 18th, 2011


"Functional genomic analysis unravels a metabolic-inflammatory interplay in ALD"

Neurometabolic Diseases Laboratory, IDIBELL, Hospital Duran i Reynals 3ª planta, Gran Via 199, 08908 L’Hospitalet de Llobregat, Barcelona, Spain. Tel: +34 932607343; Fax: +34 932607414; Email: apujol@idibell.cat
 
X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder characterized by axonopathy and demyelination in the central nervous system and adrenal insufficiency.  Read more...
 

November 17th, 2011


 Medical News Today

The FDA has approved HEMACORD, the first cord blood product ever to be approved in the USA. It used in hematopoietic stem cell transplantation procedures for individuals with disorders affecting the blood-forming system - known as the hematopoietic system. Potential patients include those with some kinds of blood cancers, as well as people with inherited metabolic and immune system disorders.


November 15th, 2011


"Stem Cell Research Goes On, Despite Canceled Trial"

 MyHealthNewsDaily
Nov 15, 2011 | 7:08 PM ET | By Rachael Rettner, MyHealthNewsDaily Staff Writer
 
Experts say they are optimistic about the future of stem cell research in the U.S., even though the first government-approved trial designed to test an embryonic stem cell therapy in people has been canceled, it was announced yesterday.  Read more...


November 14th, 2011


"MS Society Unveils Campaign for Hope"

 Notes to editors
 
The MS Society’s largest-ever fundraising appeal, for the Cambridge Centre for Myelin Repair, has been launched. The Centre has made significant breakthroughs in recent years- discovering myelin repair is possible in the lab- however £2.1m is now needed to make a treatment to repair myelin a reality.  Read more...
 

November 9th, 2011


"The Blue Ribbon Sisterhood - ALD Support "

Support Group connecting Families affect by Adrenoleukodystrophy (ALD). Together, we'll Shine Some Light on Leukodystrophies. Or visit http://www.aldsupport.org/
 

 
 
 
Research has combined stem cell technology and precision gene therapy for the first time, BBC News has reported. Read more...
 

November 8th, 2011


Published by: The Herald Gazette
 
ROCKLAND — The November meeting of Keep S’myelin will be held on Tuesday, Nov. 15, 3:30 p.m. at Kno-Wal-Lin Home Care and Hospice at 170 Pleasant St.  Read more...
 

November 7th, 2011


Published By: Raquel Maurier | raquel.maurier@ualberta.ca | University of Alberta Faculty of Medicine & Dentistry

Medical researchers at the University of Alberta have discovered that an active ingredient in the Persian spice saffron may be a potential treatment for diseases involving neuroinflammation, such as multiple sclerosis.  Read more...
 

November 1st, 2011

Published: 11/01/2011 | By: Claire O'Connell
 
 
 
SOMETIMES IN scientific research, taking a new angle can unearth unexpected but welcome discoveries.  And that’s what happened when researchers in University College Dublin’s Conway Institute looked at a type of tissue damage associated with multiple sclerosis.  Read More...